|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 05:49PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
1
|
Resverlogix Corp.
|
Jan 09, 2019 09:35AM
|
|
Re: RVX-208: Too strong or weak?
|
2
|
Resverlogix Corp.
|
Jul 21, 2016 11:41PM
|
|
Re: RVX-208 vs. CETP inhibitors
|
2
|
Resverlogix Corp.
|
Aug 18, 2015 04:34PM
|
|
Re: RVX-208 vs. CETP inhibitors
|
5
|
Resverlogix Corp.
|
Aug 19, 2015 12:34PM
|
|
Re: RVX-208 side effects
|
3
|
Resverlogix Corp.
|
Oct 30, 2016 10:56PM
|
|
Re: RVX-208 and Rosuvastatin Patent
|
2
|
Resverlogix Corp.
|
Dec 13, 2016 02:39PM
|
|
Re: RVX-208 Ameliorates Peridontal Bone Loss
|
1
|
Resverlogix Corp.
|
Jun 05, 2019 02:38PM
|
|
Re: RVX,,,,,,,,,,,,,,!
|
3
|
Resverlogix Corp.
|
Nov 23, 2015 10:46AM
|
|
Re: RVX, protein, inflammation and MS
|
4
|
Resverlogix Corp.
|
Mar 28, 2017 11:05AM
|
|
Re: RVX, protein, inflammation and MS
|
5
|
Resverlogix Corp.
|
Mar 27, 2017 02:01PM
|
|
Re: RVX vs AMRN ??
|
3
|
Resverlogix Corp.
|
Feb 14, 2019 01:49PM
|
|
Re: RVX MATERIAL CHANGE REPORT
|
3
|
Resverlogix Corp.
|
Jul 23, 2015 02:11PM
|
|
Re: RVX LIFE SCIENCES REPORT
|
6
|
Resverlogix Corp.
|
Feb 17, 2016 05:09PM
|
|
Re: RVX in the next 5 weeks
|
3
|
Resverlogix Corp.
|
Aug 20, 2016 08:43AM
|
|
Re: RVX in the next 5 weeks
|
2
|
Resverlogix Corp.
|
Aug 15, 2016 10:50AM
|
|
Re: RVX files notice of meeting...
|
2
|
Resverlogix Corp.
|
May 18, 2015 07:32AM
|
|
Re: RVX files notice of meeting...
|
3
|
Resverlogix Corp.
|
May 18, 2015 11:07AM
|
|
Re: RVX files notice of meeting...
|
3
|
Resverlogix Corp.
|
May 18, 2015 11:34AM
|
|
Re: RVX files notice of meeting...
|
3
|
Resverlogix Corp.
|
May 18, 2015 12:06PM
|
